Price Action and MACD have shown Convergence Divergence. Also a new Higher High and Higher Low Pattern seems to be in play currently. Another new MACD Crossover as well is happening now. Could this cross take the Stock to a Swing High again? While Weekly charts look good, even the MACD Cross on Monthly charts look promising as well. Let's keep an eye on this.
Note
9% Profits done so far. Trade seems to be going exactly as expected. Could hit targets sooner than expected. Keep a close eye.
Note
Weekly MACD is not looking too good currently. Price might drop down a little before it goes further up. Monthly MACD is still very much in play and looks good for long hold. Another thing to note, Stock exactly started rejecting exactly at its Swing High levels and dropping down ever since.
Trade active
Gave Max Profits of 9%. Trade at Entry Zone again. Setup still looks good, but might take a little longer than expected to reach our Targets. Keep Holding.
Note
PFIZER is back up again.
Note
Note
Just 31 points away from our Target.
Trade closed: target reached
Trade Completed. Target Achieved. Total 17% Profits booked. Time Taken = 9 weeks.
Congrats to those who made good profits with this Trade. This is how perfectly Price Action can mint you money when done right.
Trade can still be held on based on your Risk Management as the momentum still looks strong and it is possible that the Stock can go further upward.
Follow for more such Ideas! Comment any Stock that you want me to take a look into and share insights.
Kudos!!
Note
Despite a weak market this week, stock has managed to still go upward and achieve close to 23% Profits from our Entry Zone. Congrats to those who are still holding on to the trade and booking higher profits.
Trade closed: target reached
Total 32% Profits achieved from our Entry Zone. Congrats to those who are still holding on to this trade and booking higher profits.
Note
Positive News: Pfizer's RSV Vaccine Abrysvo Shows Positive Response After Single Dose.
Trade closed: target reached
Achieved 40% Profits from our Entry Zone. Congrats to those still holding on to this trade and booking bigger profits.
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.